576 results
Page 4 of 29
8-K
EX-99.1
qx0s3 c0xecu4ccr
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
hxto91vo5tvcmggyr
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-3.1
fgmktsxl3xu0
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-99.1
andqvm1
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
6rzaa5y wsw0jpwy8p0y
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
hk6f5p7x83chuv6
1 Oct 20
Contingent Value Rights Agreement
8:42am
SC TO-T/A
4es1kjrgbc9d59uhll
11 Sep 20
Third party tender offer statement (amended)
6:07am
8-K
EX-10.4
xkrqvf4kym rnc
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
n1u59hti
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
5akk11lni1firs
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
jkxpt
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
rud6ljjw
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
5isrw9svaccbdrt 66j
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-2.1
z4jhek6
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
cqym05pdu2xya05rvvj
10 Aug 20
Tender and Support Agreement
9:48pm